About the Speaker
Samuel Sia is an Associate Professor in the Department of Biomedical Engineering at Columbia University. His lab focuses on using microfluidics for global health diagnostics and for 3D tissue biology. He is a founder of Claros Diagnostics, a venture capital-backed company developing diagnostics products which was acquired by Opko Health, and Harlem Biospace, New York City's first life-science incubatorAbstract
Portable diagnostic devices have a tremendous potential for revolutionizing personal health. In U.S. and Europe, patients and consumers can have greater access to traditionally complex diagnostics, and in developing countries, mobile diagnostics provides immediate diagnosis in the field. We will discuss our lab's current efforts in these areas, in conjunction with partners in industry, public health, and local governments. Our tests span a variety of technologies, and target HIV, sexually transmitted diseases, and chronic diseases.
Next-generation POC Devices for Western and Global Health Markets
Video Jul 21, 2015
The Deadliest Being on Planet Earth – The BacteriophageVideo
A war has been raging for billions of years, killing trillions every single day, while we don’t even notice. This war involves the single deadliest being on our planet: The Bacteriophage.
Tracking Cancer With A Blood TestVideo
Blood tests that fish for either tumour DNA or cancer cells in patient blood samples are showing great promise. This type of blood analysis is helping Cancer Research UK scientists and doctors better understand the biology of cancer from its earliest origins to when it spreads around the body.WATCH NOW
3rd International Conference on Diagnostic Microbiology and Infectious Diseases
Sep 24 - Sep 25, 2018
5th edition of the International Conference Clinical Oncology and Molecular Diagnostics
Jun 17 - Jun 18, 2019